Peter Attia· MD
one of the nice things about this program is that it's designed merely to stim not merely but one of the things is designed to do is to stimulate work in other labs there are a lot of labs that are really good at cognition or heart failure or bone failure we send these people tissues all the time papers have begun to appear showing that the drug does this or it fails to do this or whatever so the hope is that for every paper we publish with a new drug that works this will trigger working a couple dozen Labs using that drug either with our tissues or with their own tissues and that some of those will come up with disease specific indications disease specific functional benefits